22nd Annual Wharton Health Care Business Conference

Speakers and Panels: Keynotes

Tom Spann

Tom Spann

Founder, Vice Chair, and Chief Operating Officer
Accolade

Since co-founding Accolade in 2007, Tom Spann has held many roles, most recently serving as CEO. “I’ve been furniture mover, printer repairman, recruiter, salesperson, reporting analyst, caterer and instigator,” he says. Through it all, Tom has led Accolade's growth on a simple principle: give people the help and information they need, and they’ll make the right choices.

In assuming the role of COO, Tom’s focus is making sure Accolade’s current clients and customers are getting thee value and service they deserve. In this capacity, he also plays a key role in determining the future of Accolade’s core product – our health assistance services and the technology that supports them and our customers.

Tom is motivated by making a “meaningful and positive difference” in the nation’s health care system and the lives of American families. He previously served as senior managing partner at Accenture, where he led the North America Products Group, a $2 billion, 10,000-employee operating unit. During his 26-year career at Accenture, Tom specialized in shaping and leading large-scale change programs including several pharmaceutical industry start-ups, most notably Astra-Merck.

Tom holds a bachelor’s degree in economics from the Wharton School of the University of Pennsylvania.

He and his wife, Nancy, have two daughters: Jenny and Meredith.

Thursday, February 18, 2016 - 6:30 PM – 9:30 PM (Lincoln Hall)

Farzad Mostashari, MD, ScM

Farzad Mostashari, MD, ScM

CEO and Founder
Aledade, Inc.

Dr. Farzad Mostashari is the CEO of Aledade, a start-up he co-founded aimed at helping primary care doctors form accountable care organizations (ACOs).

Previously, Mostashari spent time as a Visiting Fellow at the Brookings Institution in Washington DC, where he focused on payment reform and delivery system transformation. Prior to Brookings, Mostashari served from 2011-2013 as the National Coordinator for Health Information Technology where he coordinated US efforts to build a health information technology infrastructure for health care reform and consumer empowerment.

During his tenure at the Office of the National Coordinator, including his two years as Principal Deputy, he led the implementation of the Health IT for Economic and Clinical Health (HITECH) Act including the design, development and monitoring of the EHR Certification Program (including interoperability standards), the $800M Regional Health IT Extension Program (with 140,000 primary care providers, the largest medical technical assistance program in US history), the “Beacon Communities” program and collaborated with the Centers for Medicare and Medicaid Services on the design and implementation of the “Meaningful Use” Incentive Program (garnering participation of >85% of eligible hospitals, and >74% of eligible professionals nationwide), in addition to programs for health information exchange, health IT workforce, research and privacy and security.

This period saw a dramatic increase in adoption of Electronic Health Records (EHRs)—from 9→44% among hospitals, and 17→40% among outpatient providers (latest data as of mid-2012). Under his leadership, the agency was recognized as one of the top 25 “Innovations in Government” by the Harvard Kennedy School of Government in 2013.

Previously, Mostashari served at the New York City Department of Health and Mental Hygiene as Assistant Commissioner for the Primary Care Information Project, where he co-led agile development of population health management functionality within a commercial EHR, and its adoption by more than 1,500 providers in underserved communities. Mostashari also led the NYC Center of Excellence in Public Health Informatics and an Agency for Healthcare Research and Quality-funded project focused on quality measurement at the point of care.

He conducted graduate training at the Harvard School of Public Health and Yale Medical School, served his internal medicine residency at Massachusetts General Hospital, and completed the CDC’s Epidemic Intelligence Service program. He was a lead investigator in the outbreaks of West Nile Virus, and anthrax in New York City and among the first developers of real-time nationwide electronic disease surveillance systems.

Friday, February 19, 2016 - 8:30 AM – 9:15 AM (Lincoln Hall)

John C. Lechleiter, PhD

John C. Lechleiter, PhD

Chairman, President, and Chief Executive Officer
Eli Lilly and Company

John Lechleiter has served as president and chief executive officer of Eli Lilly and Company since April 1, 2008. He became chairman of the board of directors on January 1, 2009.

John joined Lilly in 1979 as a senior organic chemist in process research and development and became head of that department in 1982. In 1984, he began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England. He later held roles in project management, regulatory affairs, product development, and pharma operations. In 2005, he was named president and chief operating officer and joined the board of directors.

John earned a bachelor’s degree in chemistry from Xavier University and master’s and doctoral degrees in organic chemistry from Harvard University. John has received honorary doctorates from Marian University (Indianapolis, Indiana), the University of Indianapolis, the National University of Ireland, Indiana University, and Franklin College.

John is a member of the American Chemical Society. He serves on the board of the Pharmaceutical Research and Manufacturers of America (PhRMA), as chairman of the U.S.-Japan Business Council and of United Way Worldwide, and on the boards of the Chemical Heritage Foundation and the Central Indiana Corporate Partnership. He also serves on the boards of Nike, Inc. and Ford Motor Company.

Friday, February 19, 2016 - 3:35 PM – 4:20 PM (Lincoln Hall)

Capstone Event

Friday, February 19, 2016 - 4:30 PM – 5:30 PM (Lincoln Hall)


Mark McClellan, MD, PhD

Mark McClellan, MD, PhD

Robert J. Margolis Professor of Business, Medicine, and Policy, and Director, Duke-Margolis Center for Health Policy
Duke University

Mark McClellan, MD, PhD, is the Robert J. Margolis Professor of Business, Medicine, and Policy, and Director of the Duke-Margolis Center for Health Policy at Duke University with offices at Duke and in Washington DC. The new Center will support and conduct research, evaluation, implementation, and educational activities to improve health policy and health, through collaboration across Duke University and Health System, and through partnerships between the public and private sectors. It integrates the social, clinical, and analytical sciences to integrate technical expertise and practical capabilities to develop and apply policy solutions that improve health and the value of health care locally, nationally, and worldwide.

Dr. McClellan is a doctor and an economist, and his work has addressed a wide range of strategies and policy reforms to improve health care, including such areas as payment reform to promote better outcomes and lower costs, methods for development and use of real-world evidence, and more effective drug and device innovation. Before coming to Duke, he served as a Senior Fellow in Economic Studies at the Brookings Institution, where he was Director of the Health Care Innovation and Value Initiatives and led the Richard Merkin Initiative on Payment Reform and Clinical Leadership. He also has a highly distinguished record in public service and in academic research. Dr. McClellan is a former administrator of the Centers for Medicare & Medicaid Services (CMS) and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative, and public-private initiatives to develop better information on the quality and cost of care.

Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA, is a member of the National Academy of Medicine and chairs the Academy’s Leadership Council for Value and Science-Driven Health care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network, and is a research associate at the National Bureau of Economic Research. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House, and as Deputy Assistant Secretary for Economic Policy at the Department of the Treasury. He was previously an associate professor of economics and medicine with tenure at Stanford University, and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.


Cybele Bjorklund

Cybele Bjorklund

Distinguished Visitor, O’Neill Institute for National and Global Health Law, Law Center
Senior Fellow, McCourt School of Public Policy
Georgetown University

Cybele Bjorklund is Distinguished Visitor at the O’Neill Institute for National and Global Health Law at Georgetown University’s Law Center and a Senior Fellow at Georgetown University’s McCourt School of Public Policy. Bjorklund also currently serves as a Council Member for the Gerson Lehrman Group (GLG) and is on Health Advisory Board for APCO Public Affairs.

During nearly 21 years of federal service, Bjorklund was at the center of virtually every major Medicare debate. She also had a leading role in the creation and enactment of the Affordable Care Act, and in many other laws affecting Medicare and private health insurance, including the health information technology (IT) and comparative effectiveness research (CER) provisions enacted in the Economic Recovery Act of 2009.

Bjorklund left the Committee on Ways and Means in the United States House of Representatives in 2015, where she had been the Democratic Staff Director for the Subcommittee on Health and senior health advisor to full Committee members since 2001. The Committee’s health portfolio includes Medicare, selected provisions in the Affordable Care Act, private health insurance, and other health issues in the Internal Revenue Code.

From 1997-2001, she served as Senator Edward Kennedy’s (D-MA) deputy staff director for health policy on the Health, Education, Labor and Pensions (HELP) Committee in the United States Senate. In this capacity, Bjorklund provided policy guidance during the development and enactment of the state Children’s Health Insurance Program (CHIP), and developed and advanced a variety of legislative initiatives, including the Patients’ Bill of Rights, medical privacy, HIPAA implementation, reauthorization of the Agency for Healthcare Research and Quality, and other public health initiatives and insurance reform legislation. She also spearheaded an effort to lay groundwork for creation of a Medicare prescription drug benefit.

From 1995-1997, she worked as a legislative aide on health and veterans’ issues for Senate Democratic Leader Tom Daschle (D-SD), covering Medicare reform during the Balanced Budget Act debates of 1995-1997 and other issues. Before moving to Congress, Bjorklund was a Medicare and insurance policy analyst at the Health Care Financing Administration (now the Centers for Medicare and Medicaid Services) within the U.S. Department of Health & Human Services.

Bjorklund serves on the Policy Advisory Committee for the Medicare Rights Center, is a member of the National Academy of Social Insurance and is on the board of directors and executive committee for the David A. Winston Health Policy Fellowship. She received a master’s degree from The Johns Hopkins University’s School of Hygiene and Public Health, with an emphasis on health policy and a concentration in law, ethics and policy, and a bachelor’s degree in journalism from the School of Journalism at the University of Oregon.


Mark McClellan, MD, PhD and Cybele Bjorklund’s discussion will be moderated by Elisabeth Rosenthal, MD


Elisabeth Rosenthal, MD

Elisabeth Rosenthal, MD

Senior Correspondent, Healthcare and Economics
New York Times

Elisabeth Rosenthal, MD, is a New York Times senior correspondent focusing on health care and health economics. In her 20+ years with the newspaper she has covered a wide variety of beats, including New York City hospitals, international environment reporting and general assignment reporting from Beijing, China. In 2013 to 2014 she authored the prize-winning series, “Paying Till it Hurts,” exploring the high costs and prices associated with even ordinary encounters in U.S. medicine. For that work, she won the 2014 Victor Cohn Prize for Excellence in Medical Science Reporting, First Prize from the Association of Healthcare Journalists, and the New York Times’ first Online Journalism Award. Rosenthal has been a Poynter Fellow at Yale, a Ferris Visiting Professor at Princeton and has lectured at medical, law and business school nationally about her work. She holds BS (biology) and BA (history) degrees with high honors from Stanford University and an M.A. in English literature from Cambridge University, where she was a Marshall scholar. Rosenthal earned an MD from Harvard Medical School, training in internal medicine and working briefly as an emergency medicine physician before turning to journalism full-time. She is currently writing a book on the commercialization of U.S. medicine to be published by Penguin Random House.

Wharton HCC Website

Be sure to visit the new Wharton Healthcare Club Website for the latest information on the Wharton healthcare community including upcoming events and industry speaker series lectures.

Visit HCC Website

WHCBC@Social

Connect with other conference attendees, speakers, and panelists ahead of the conference, and follow the latest updates.

Pulse Magazine

The Pulse - 2016 Edition

The Pulse is an annual publication which is distributed to all attendees of this Conference.

Download

The Wharton Health Care Conference is not just the best conference organized by students but one of the most impressive gatherings of industry leaders tackling timely and important issues in the health care industry.

Stelios Papadopoulos, Ph.D., Chairman and Founder, Exelixis

Sponsors


Bronze Sponsors

AmerisourceBergen Cigna Kindred Healthcare Regeneron

Sponsors

BDO Change Healthcare Genentech Johnson & Johnson Eli Lilly Lumeris Medtronic MTS Health Partners Oliver Wyman Penn Biotech Group Welltok